| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 2.463 | 3.760 | 5.010 | 6.619 | 9.761 | 5.649 | 8.292 | 5.503 | 5.447 |
| Total Income - EUR | - | 2.463 | 3.763 | 5.012 | 6.673 | 9.782 | 5.649 | 8.292 | 5.503 | 5.447 |
| Total Expenses - EUR | - | 237 | 1.851 | 670 | 530 | 78 | 484 | 582 | 1.115 | 117 |
| Gross Profit/Loss - EUR | - | 2.226 | 1.913 | 4.343 | 6.144 | 9.705 | 5.165 | 7.710 | 4.389 | 5.330 |
| Net Profit/Loss - EUR | - | 2.152 | 1.800 | 4.192 | 5.943 | 9.416 | 4.999 | 7.466 | 3.609 | 4.494 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Almar Clinical Research Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 36 | 945 | 415 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | 2.524 | 1.107 | 3.979 | 10.249 | 9.893 | 5.437 | 10.116 | 3.832 | 8.232 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 0 | 0 | 666 | 1.734 | 1.506 | 1.224 | 7.744 | 1.192 | 5.231 |
| Cash | - | 2.524 | 1.107 | 3.313 | 8.515 | 8.387 | 4.213 | 2.372 | 2.640 | 3.001 |
| Shareholders Funds | - | 2.196 | 1.848 | 4.244 | 5.994 | 9.465 | 5.047 | 7.515 | 3.658 | 4.543 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 364 | 204 | 150 | 4.255 | 428 | 390 | 2.601 | 174 | 3.690 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7210 - 7210" | |||||||||
| CAEN Financial Year |
7211
|
|||||||||
Comments - Almar Clinical Research Srl